YONGHE MED.GR.DL-0000025 (L97) - Total Liabilities
Based on the latest financial reports, YONGHE MED.GR.DL-0000025 (L97) has total liabilities worth €914.47 Million EUR (≈ $1.07 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of YONGHE MED.GR.DL-0000025 to evaluate the company's liquid asset resilience ratio.
YONGHE MED.GR.DL-0000025 - Total Liabilities Trend (2021–2025)
This chart illustrates how YONGHE MED.GR.DL-0000025's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is YONGHE MED.GR.DL-0000025's balance sheet.
YONGHE MED.GR.DL-0000025 Competitors by Total Liabilities
The table below lists competitors of YONGHE MED.GR.DL-0000025 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Garuda Metalindo Tbk PT
JK:BOLT
|
Indonesia | Rp581.39 Billion |
|
Nava Nakorn Public Company Limited
BK:NNCL
|
Thailand | ฿1.11 Billion |
|
Coya Therapeutics, Inc. Common Stock
NASDAQ:COYA
|
USA | $4.03 Billion |
|
APCB Inc
TW:6108
|
Taiwan | NT$4.25 Billion |
|
Lokum Deweloper SA
WAR:LKD
|
Poland | zł281.65 Million |
|
Jaeyoung Solutec Co. Ltd
KQ:049630
|
Korea | ₩104.92 Billion |
|
Dhampur Sugar Mills Limited
NSE:DHAMPURSUG
|
India | Rs12.17 Billion |
|
Idsud S.A
PA:ALIDS
|
France | €8.95 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down YONGHE MED.GR.DL-0000025's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See YONGHE MED.GR.DL-0000025 net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.55 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.16 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.54 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how YONGHE MED.GR.DL-0000025's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for YONGHE MED.GR.DL-0000025 (2021–2025)
The table below shows the annual total liabilities of YONGHE MED.GR.DL-0000025 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €914.47 Million ≈ $1.07 Billion |
-9.67% |
| 2024-12-31 | €1.01 Billion ≈ $1.18 Billion |
-32.61% |
| 2023-12-31 | €1.50 Billion ≈ $1.76 Billion |
+11.69% |
| 2022-12-31 | €1.35 Billion ≈ $1.57 Billion |
-10.39% |
| 2021-12-31 | €1.50 Billion ≈ $1.75 Billion |
-- |
About YONGHE MED.GR.DL-0000025
Yonghe Medical Group Co., Ltd. provides hair-related healthcare services in China. The company offers hair transplant, medical hair care, routine hair restoration, and other ancillary services. It also engages provision of hair research and consulting services; investment and management; and wig business. The company was founded in 2005 and is headquartered in Beijing, China.